REFERENCES
- Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. New Engl J Med 1997; 336: 708–16.
- Tuomanen E, Liu H, Hengstler B, Zak O, Tomasz A. The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis 1985; 151: 859–68.
- Cabellos C, Martinez-Lacasa J, Martos A, Tubau F, Fernández A, Viladrich PF, et al. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrob Agents Chemother 1995; 39: 2158–60.
- Paris MM, Hickey SM, Uscher MI, Shelton S, Olsen KD, McCracken GH. Effect of dexamethasone on experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1994; 38: 1320–4.
- Zysk G, Brück W, Gerber J, Brück Y, Prange HW, Nau R. Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J Neuropathol Exp Neurol 1996; 55: 722–8.
- Stuertz K, Schmidt H, Eiffert H, Mader M, Nau R. Differential release of lipoteichoic and teichoic acids from Streptococcus pneumoniae by β-lactam antibiotics, rifamycins, trovafloxacin, and quinupristin/dalfopristin. Antimicrob Agents Chemother 1998; 42: 277–81.
- Nau R, Zysk G, Schmidt H, Fischer FR, Stringaris A, Stuertz K, Brück W. Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis. J Antimicrob Chemother 1997; 39: 781–8.
- Schmidt H, Zysk G, Reinert RR, Brück W, Stringaris A, Chen V et al. Rifabutin for experimental pneumococcal meningitis. Chemotherapy 1997; 43: 264–71.
- Schmidt H, Dalhoff A, Stuertz K, Trostdorf F, Chen V, Kohlsdorfer C, et al. Moxifloxacin in the therapy of experimental pneumococcal meningitis. Antimicrob Agents Chemother 1998; 42: 1397–401.
- Trostdorf F, Reinert RR, Schmidt H, Nichterlein T, Stuertz K, Schmitz-Salue M, et al. Quinnpristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis. J Antimicrob Chemother 1999; 43: 87–94.
- Goerz G, Greither A. Spezifische Behandlung der Neurosyphilis. Med Welt 1973; 24: 980–2.
- Jackson JJ, Kropp H. β-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis 1992; 165: 1033–41.
- Dodge PR, Swartz MN. Bacterial meningitis – a review of selected aspects. II. Special neurologic problems, postmeningitic complications and clinicopathological correlations. New Engl J Med 1965; 272: 954–60, 1003–10.
- Täuber MG, Shibl AM, Hackbarth CJ, Larrick JW, Sande MA. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J Infect Dis 1987; 156: 456–62.
- Kim YS, Tauber MG. Neurotoxicity of glia activated by gram-positive bacterial products depends on nitric oxide production. Infect Immun 1996; 64: 3148–53.